IX Biopharma    Last:0.355    +0.01

iX Biopharma

Buyer coming? Going grrem?

piscesmonkey      ( Date: 17-Apr-2026 13:35) Posted: Look like i need to hold liao. Wait for next week to chiong up today some profit taking

 

Cos of ceasefire talk during weekend. If got deal next week chiong up

tofudidi      ( Date: 17-Apr-2026 13:54) Posted: looks like some bad news coming over the weekend? market seems to lean towards red.. sideline safe for now

 

RH?

RODSTEWARD      ( Date: 17-Apr-2026 13:49) Posted: Hope not another RH - once boss sells the Stop button on

 

looks like some bad news coming over the weekend? market seems to lean towards red.. sideline safe for now 

 

Hope not another RH - once boss sells the Stop button on

 

Look like i need to hold liao. Wait for next week to chiong up today some profit taking

 

Bec all waiting . Price little movement . Longist waiting for better price . Shortist don?t dare to short .

parcvista      ( Date: 17-Apr-2026 11:56) Posted: Is so quiet here today

 

Is so quiet here today

 

Added another 100lots at 415 wait for next week run up

 

😄 I am not full of bullishness instead thing may turn sour if the management not handling thing well... hope that we can hear some annoucement instead we keeping in a dark, happy vesting, cheer.

makehay      ( Date: 17-Apr-2026 07:36) Posted: yes, selling the future, that is what it is about.  on the point of more investors coming in. so will the CEO and wife sell more shares to lower their holding for instiutional investors to come in? somehow, you are full of bullishness in everything. Selling the future is easy, based on potential of more licensing, etc. certainly would like to hear those announcement and that will be natural price progression.   Elf2000      ( Date: 17-Apr-2026 02:56) Posted: I see where you&rsquo re coming from, but there&rsquo s another way to look at it for iX Biopharma Ltd..   Short-term price movements like jumping from 33c to 45c in a few days can look &ldquo orchestrated,&rdquo but that kind of volatility is actually quite common in small-cap biotech counters&mdash especially when there&rsquo s new funding or corporate activity like a placement. These events tend to reset the price range rather than represent the final ceiling.   On the placement point, doing it around ~42.5c can also be interpreted positively:   .It shows investor willingness to come in at a higher base, not at distressed levels   .It strengthens the company&rsquo s balance sheet, which is critical for biotech execution   .It provides funding to push commercialization (which is where real value comes from)     Regarding the CEO and his wife holding below 30%, I wouldn&rsquo t read that negatively. In fact:   .A ~20%+ stake is already very significant skin in the game   .Keeping it below 30% avoids triggering takeover obligations under SGX rules   .It also leaves room for institutional investors to come in, which can support longer-term growth   As for &ldquo who will push it higher,&rdquo ultimately it won&rsquo t be trading action&mdash it will be business delivery:   .Revenue traction from their drug delivery platform   .Commercial progress in key markets   .Partnerships or licensing deals   If those fundamentals play out, the share price will take care of itself over time.

 

50cents? Alot investors coming

 

yes, selling the future, that is what it is about. 
on the point of more investors coming in. so will the CEO and wife sell more shares to lower their holding for instiutional investors to come in?

somehow, you are full of bullishness in everything. Selling the future is easy, based on potential of more licensing, etc. certainly would like to hear those announcement and that will be natural price progression.
 

Elf2000      ( Date: 17-Apr-2026 02:56) Posted: I see where you&rsquo re coming from, but there&rsquo s another way to look at it for iX Biopharma Ltd..   Short-term price movements like jumping from 33c to 45c in a few days can look &ldquo orchestrated,&rdquo but that kind of volatility is actually quite common in small-cap biotech counters&mdash especially when there&rsquo s new funding or corporate activity like a placement. These events tend to reset the price range rather than represent the final ceiling.   On the placement point, doing it around ~42.5c can also be interpreted positively:   .It shows investor willingness to come in at a higher base, not at distressed levels   .It strengthens the company&rsquo s balance sheet, which is critical for biotech execution   .It provides funding to push commercialization (which is where real value comes from)     Regarding the CEO and his wife holding below 30%, I wouldn&rsquo t read that negatively. In fact:   .A ~20%+ stake is already very significant skin in the game   .Keeping it below 30% avoids triggering takeover obligations under SGX rules   .It also leaves room for institutional investors to come in, which can support longer-term growth   As for &ldquo who will push it higher,&rdquo ultimately it won&rsquo t be trading action&mdash it will be business delivery:   .Revenue traction from their drug delivery platform   .Commercial progress in key markets   .Partnerships or licensing deals   If those fundamentals play out, the share price will take care of itself over time. makehay      ( Date: 16-Apr-2026 22:28) Posted: In many companies, directors paid with shares usually already at the top. of course, the stock cannot go up in a straight line. Just see how the prices got pushed up from 33c to 43c in one day. and next day gap up at 45.5 ended 42.5 and today dropped to 38 and pushed back to 45.5 high This is simply an elaborate orchestration for prices to be at this level for the placement and director' s fee.  3 days of work. who is going to be pushing this higher now?  as for the substantial shareholder who already got the stock at much lower level. getting placement at 42.5 got a lot of shock absorber already How many substantial shareholder involved? only one.  And I wonder why the CEO and his wife would have total shareowner ship lower than 30% since the future is so bright?

 

I wonder if you know in company structures, what it takes to be owning a certain level to maintain control? certain less than 30% doesnt cut it. 

Elf2000      ( Date: 17-Apr-2026 02:56) Posted: I see where you&rsquo re coming from, but there&rsquo s another way to look at it for iX Biopharma Ltd..   Short-term price movements like jumping from 33c to 45c in a few days can look &ldquo orchestrated,&rdquo but that kind of volatility is actually quite common in small-cap biotech counters&mdash especially when there&rsquo s new funding or corporate activity like a placement. These events tend to reset the price range rather than represent the final ceiling.   On the placement point, doing it around ~42.5c can also be interpreted positively:   .It shows investor willingness to come in at a higher base, not at distressed levels   .It strengthens the company&rsquo s balance sheet, which is critical for biotech execution   .It provides funding to push commercialization (which is where real value comes from)     Regarding the CEO and his wife holding below 30%, I wouldn&rsquo t read that negatively. In fact:   .A ~20%+ stake is already very significant skin in the game   .Keeping it below 30% avoids triggering takeover obligations under SGX rules   .It also leaves room for institutional investors to come in, which can support longer-term growth   As for &ldquo who will push it higher,&rdquo ultimately it won&rsquo t be trading action&mdash it will be business delivery:   .Revenue traction from their drug delivery platform   .Commercial progress in key markets   .Partnerships or licensing deals   If those fundamentals play out, the share price will take care of itself over time. makehay      ( Date: 16-Apr-2026 22:28) Posted: In many companies, directors paid with shares usually already at the top. of course, the stock cannot go up in a straight line. Just see how the prices got pushed up from 33c to 43c in one day. and next day gap up at 45.5 ended 42.5 and today dropped to 38 and pushed back to 45.5 high This is simply an elaborate orchestration for prices to be at this level for the placement and director' s fee.  3 days of work. who is going to be pushing this higher now?  as for the substantial shareholder who already got the stock at much lower level. getting placement at 42.5 got a lot of shock absorber already How many substantial shareholder involved? only one.  And I wonder why the CEO and his wife would have total shareowner ship lower than 30% since the future is so bright?

 

Wah, excellent writeup and clear justification.
Pays to invest when you understand the business and the fundamentals.
Let's see how far IX BioPharm will go.
My target still $1.

Elf2000      ( Date: 17-Apr-2026 02:56) Posted: I see where you&rsquo re coming from, but there&rsquo s another way to look at it for iX Biopharma Ltd..   Short-term price movements like jumping from 33c to 45c in a few days can look &ldquo orchestrated,&rdquo but that kind of volatility is actually quite common in small-cap biotech counters&mdash especially when there&rsquo s new funding or corporate activity like a placement. These events tend to reset the price range rather than represent the final ceiling.   On the placement point, doing it around ~42.5c can also be interpreted positively:   .It shows investor willingness to come in at a higher base, not at distressed levels   .It strengthens the company&rsquo s balance sheet, which is critical for biotech execution   .It provides funding to push commercialization (which is where real value comes from)     Regarding the CEO and his wife holding below 30%, I wouldn&rsquo t read that negatively. In fact:   .A ~20%+ stake is already very significant skin in the game   .Keeping it below 30% avoids triggering takeover obligations under SGX rules   .It also leaves room for institutional investors to come in, which can support longer-term growth   As for &ldquo who will push it higher,&rdquo ultimately it won&rsquo t be trading action&mdash it will be business delivery:   .Revenue traction from their drug delivery platform   .Commercial progress in key markets   .Partnerships or licensing deals   If those fundamentals play out, the share price will take care of itself over time. makehay      ( Date: 16-Apr-2026 22:28) Posted: In many companies, directors paid with shares usually already at the top. of course, the stock cannot go up in a straight line. Just see how the prices got pushed up from 33c to 43c in one day. and next day gap up at 45.5 ended 42.5 and today dropped to 38 and pushed back to 45.5 high This is simply an elaborate orchestration for prices to be at this level for the placement and director' s fee.  3 days of work. who is going to be pushing this higher now?  as for the substantial shareholder who already got the stock at much lower level. getting placement at 42.5 got a lot of shock absorber already How many substantial shareholder involved? only one.  And I wonder why the CEO and his wife would have total shareowner ship lower than 30% since the future is so bright?

 

makehay      ( Date: 16-Apr-2026 22:28) Posted: In many companies, directors paid with shares usually already at the top. of course, the stock cannot go up in a straight line. Just see how the prices got pushed up from 33c to 43c in one day. and next day gap up at 45.5 ended 42.5 and today dropped to 38 and pushed back to 45.5 high This is simply an elaborate orchestration for prices to be at this level for the placement and director' s fee.  3 days of work. who is going to be pushing this higher now?  as for the substantial shareholder who already got the stock at much lower level. getting placement at 42.5 got a lot of shock absorber already How many substantial shareholder involved? only one.  And I wonder why the CEO and his wife would have total shareowner ship lower than 30% since the future is so bright?  Elf2000      ( Date: 16-Apr-2026 22:05) Posted: Another positive point: The directors are also taking 304,270 shares instead of cash fees.   This is usually seen as a good sign of alignment because directors are accepting shares in lieu of fees, which may imply they are willing to stay invested in the company&rsquo s future upside.   In simple words: management is willing to &ldquo eat their own cooking&rdquo   This often gives investors some reassurance.   TP still intact.

 

He must have sold . Historically share issue near to last closing price after increase so much will have further growth .. haha . Huat for those who have long

stlimst      ( Date: 16-Apr-2026 23:04) Posted: Fair enough Bro makehay. So IX BioPharma is not your cup of tea (or stack of hay..haha).   makehay      ( Date: 16-Apr-2026 22:28) Posted: In many companies, directors paid with shares usually already at the top. of course, the stock cannot go up in a straight line. Just see how the prices got pushed up from 33c to 43c in one day. and next day gap up at 45.5 ended 42.5 and today dropped to 38 and pushed back to 45.5 high This is simply an elaborate orchestration for prices to be at this level for the placement and director' s fee.  3 days of work. who is going to be pushing this higher now?  as for the substantial shareholder who already got the stock at much lower level. getting placement at 42.5 got a lot of shock absorber already How many substantial shareholder involved? only one.  And I wonder why the CEO and his wife would have total shareowner ship lower than 30% since the future is so bright?

 

Fair enough Bro makehay.
So IX BioPharma is not your cup of tea (or stack of hay..haha).
 

makehay      ( Date: 16-Apr-2026 22:28) Posted: In many companies, directors paid with shares usually already at the top. of course, the stock cannot go up in a straight line. Just see how the prices got pushed up from 33c to 43c in one day. and next day gap up at 45.5 ended 42.5 and today dropped to 38 and pushed back to 45.5 high This is simply an elaborate orchestration for prices to be at this level for the placement and director' s fee.  3 days of work. who is going to be pushing this higher now?  as for the substantial shareholder who already got the stock at much lower level. getting placement at 42.5 got a lot of shock absorber already How many substantial shareholder involved? only one.  And I wonder why the CEO and his wife would have total shareowner ship lower than 30% since the future is so bright?  Elf2000      ( Date: 16-Apr-2026 22:05) Posted: Another positive point: The directors are also taking 304,270 shares instead of cash fees.   This is usually seen as a good sign of alignment because directors are accepting shares in lieu of fees, which may imply they are willing to stay invested in the company&rsquo s future upside.   In simple words: management is willing to &ldquo eat their own cooking&rdquo   This often gives investors some reassurance.   TP still intact.

 

In many companies, directors paid with shares usually already at the top. of course, the stock cannot go up in a straight line. Just see how the prices got pushed up from 33c to 43c in one day. and next day gap up at 45.5 ended 42.5 and today dropped to 38 and pushed back to 45.5 high

This is simply an elaborate orchestration for prices to be at this level for the placement and director' s fee. 
3 days of work. who is going to be pushing this higher now?  as for the substantial shareholder who already got the stock at much lower level. getting placement at 42.5 got a lot of shock absorber already

How many substantial shareholder involved? only one. 
And I wonder why the CEO and his wife would have total shareowner ship lower than 30% since the future is so bright? 

Elf2000      ( Date: 16-Apr-2026 22:05) Posted: Another positive point: The directors are also taking 304,270 shares instead of cash fees.   This is usually seen as a good sign of alignment because directors are accepting shares in lieu of fees, which may imply they are willing to stay invested in the company&rsquo s future upside.   In simple words: management is willing to &ldquo eat their own cooking&rdquo   This often gives investors some reassurance.   TP still intact. stlimst      ( Date: 16-Apr-2026 21:52) Posted: Positive news. Placement to an existing SSH @$0.4215. and issue of shares to directors in lieu of directors fees. Again showing the confidence of SSH and directors have in the company. Let this ride out to $1.

 

stlimst      ( Date: 16-Apr-2026 21:52) Posted: Positive news. Placement to an existing SSH @$0.4215. and issue of shares to directors in lieu of directors fees. Again showing the confidence of SSH and directors have in the company. Let this ride out to $1.  piscesmonkey      ( Date: 16-Apr-2026 20:53) Posted: The board of directors (the ?Directors?) of iX Biopharma Ltd. (the ?Company?, together with its subsidiaries, the ?Group?) wishes to announce that: (a) the Company has on 16 April 2026 entered into a conditional subscription agreement (the ?Subscription Agreement?) with Anson Properties Pte. Ltd. (the ?Subscriber?) pursuant to which the Subscriber has agreed to subscribe for an aggregate of 1,045,164 new ordinary shares in the capital of the Company (the ?Subscription Shares?) at an issue price of S$0.4215 per Subscription Share (the ?Issue Price?) with the aggregate gross proceeds amounting to S$440,537 (the ?Anson Placement?) and (b) the Company proposes to issue an aggregate of 304,270 new ordinary shares (the ?Directors? Shares?) at the Issue Price to certain Directors in lieu of Directors? fees for the period from 1 October 2025 to 31 March 2026 (the ?Directors? Placement?).

 

Positive news.
Placement to an existing SSH @$0.4215. and issue of shares to directors in lieu of directors fees.
Again showing the confidence of SSH and directors have in the company.

Let this ride out to $1. 

piscesmonkey      ( Date: 16-Apr-2026 20:53) Posted: The board of directors (the ?Directors?) of iX Biopharma Ltd. (the ?Company?, together with its subsidiaries, the ?Group?) wishes to announce that: (a) the Company has on 16 April 2026 entered into a conditional subscription agreement (the ?Subscription Agreement?) with Anson Properties Pte. Ltd. (the ?Subscriber?) pursuant to which the Subscriber has agreed to subscribe for an aggregate of 1,045,164 new ordinary shares in the capital of the Company (the ?Subscription Shares?) at an issue price of S$0.4215 per Subscription Share (the ?Issue Price?) with the aggregate gross proceeds amounting to S$440,537 (the ?Anson Placement?) and (b) the Company proposes to issue an aggregate of 304,270 new ordinary shares (the ?Directors? Shares?) at the Issue Price to certain Directors in lieu of Directors? fees for the period from 1 October 2025 to 31 March 2026 (the ?Directors? Placement?).